PharmaShots | Incisive News in 3 Shots

Subscribe Now

Rare Cancer Indications

Innovent Biologics and MD Anderson Collaborate to Co-develop TYVYT (sintilimab) in Rare Cancer Indications in the US

Innovent Biologics and MD Anderson Collaborate to Co-develop TYVYT (sintilimab) in Rare Cancer Indications in the US

May 19, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us